Abbvie Inc
NYSE:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbvie Inc
NYSE:ABBV
|
US |
|
Hilton Worldwide Holdings Inc
NYSE:HLT
|
US |
|
R
|
Reinet Investments SCA
JSE:RNI
|
LU |
|
CuriosityStream Inc
NASDAQ:CURI
|
US |
|
Sekisui House Ltd
TSE:1928
|
JP |
|
Artisanal Spirits Company PLC
LSE:ART
|
UK |
|
WSP Global Inc
TSX:WSP
|
CA |
|
Hokuriku Electric Power Co
TSE:9505
|
JP |
|
AES Corp
NYSE:AES
|
US |
|
Lamar Advertising Co
NASDAQ:LAMR
|
US |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
F
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
US |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 257.55 USD with a low forecast of 189.76 USD and a high forecast of 344.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
257.55
USD
According to Wall Street analysts, the average 1-year price target for ABBV is 257.55 USD with a low forecast of 189.76 USD and a high forecast of 344.4 USD.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.
